Filing Details

Accession Number:
0001593968-21-001633
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-16 19:01:27
Reporting Period:
2021-06-14
Accepted Time:
2021-06-16 19:01:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1771917 Karuna Therapeutics Inc. KRTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1579829 A. Troy Ignelzi C/O Karuna Therapeutics, Inc.
99 High Street, 26Th Floor
Boston MA 02110
Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-16 2,248 $9.20 15,248 No 4 M Direct
Common Stock Disposition 2021-06-16 2,248 $129.45 13,000 No 4 S Direct
Common Stock Acquisiton 2021-06-14 900 $9.20 13,900 No 4 M Direct
Common Stock Disposition 2021-06-14 900 $132.52 13,000 No 4 S Direct
Common Stock Acquisiton 2021-06-16 352 $9.20 13,352 No 4 M Direct
Common Stock Disposition 2021-06-16 352 $128.40 13,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (right to buy) Disposition 2021-06-16 2,248 $0.00 2,248 $9.20
Common Stock Option (right to buy) Disposition 2021-06-14 900 $0.00 900 $9.20
Common Stock Option (right to buy) Disposition 2021-06-16 352 $0.00 352 $9.20
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,031 2029-03-28 No 4 M Direct
1,605 2029-04-07 No 4 M Direct
1,253 2029-04-07 No 4 M Direct
Footnotes
  1. This option vests and becomes exercisable in thirty-six equal monthly installments beginning on April 1, 2019.